Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dual Bronchodilatation on Broncholysis Testing in COPD Patients
2014-002667-15Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of glycopyrronium, indacaterol and salbutamol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Medical University of Innsbruck. Primary endpoint: Change in postbronchodilator FEV1 vs baseline. Started Aug 2014; status: completed.
02
Drugs
glycopyrroniumindacaterolsalbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2014-002667-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002667-15.